Adagene Inc. (ADAG) Financials

ADAG Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 66.5 million 28.6 million
Dec. 31, 2024 89.3 million 38.7 million
Sept. 30, 2024 100.8 million 44.2 million
June 30, 2024 100.8 million 44.2 million

ADAG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -11.2 million ?
Dec. 31, 2024 -23.0 million 2.9 million
Sept. 30, 2024 -6.7 million 2.0 million
June 30, 2024 -6.7 million 2.0 million

ADAG Net Income

No data available :(

ADAG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 62.8 million - 88706
Dec. 31, 2024 85.2 million 417339 283645
Sept. 30, 2024 95.7 million - -
June 30, 2024 95.7 million 4.6 million 255367

ADAG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 37.7 million
Dec. 31, 2024 36.7 million
Sept. 30, 2024 35.3 million
June 30, 2024 44.2 million

ADAG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 2499 11.7 million 3.7 million -
Dec. 31, 2024 27306 20.5 million 3.7 million -
Sept. 30, 2024 6274 7.4 million 1.8 million 1.8 million
June 30, 2024 6274 7.4 million 1.8 million 1.8 million

ADAG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 - 300326
Dec. 31, 2024 103204 926248
Sept. 30, 2024 - -
June 30, 2024 - -

ADAG

Price: $3.57

52 week price:
1.30
4.75

Earnings Per Share: -0.38 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: China

Volume: 47600

Market Capitalization: 133.9 million

Links: